News|Articles|February 13, 2018

Particulates, Endotoxins, and Bioburden Characterization of Silicone Tubing for Biopharmaceutical Applications

External Link - PTE0218 Dow-Siv F&C pr2f-Web.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching

ByManish Garg, PMP, PSM

July 16th 2026

FDA concept. Concept of the Food and Drug Administration. Magnifier glass, folder and clock | Image credit: © Sviatlana - © Sviatlana-stock.adobe.com

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

ByFeliza Mirasol,Jeffrey C. Mocny,Anna McMahon

July 15th 2026

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One

ByRichard Jaenisch,Christopher Cole

July 15th 2026

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

FDA Activity Round Up – July 2026

ByZachary Zubulake

July 15th 2026

test tube ampoule syringe flag europe doctor vaccine medicine | Image Credit: ©NataliAlba -stock.adobe.com

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

BySusan Haigney

July 15th 2026

Particulates, Endotoxins, and Bioburden Characterization of Silicone Tubing for Biopharmaceutical Applications

Related Content

Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One

FDA Activity Round Up – July 2026

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

Trending on Pharmaceutical Technology

FDA Activity Round Up – July 2026

Using Automation to Enhance Pharmaceutical Manufacturing

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

Hidden Cost Drivers in Oligonucleotide Manufacturing

Mid-Year Check-In: Are Henrik Johanning's Pharma Manufacturing Predictions Holding Up?